N5-(imino(propylamino)methyl)-L-ornithine,
N5-(imino(propylamino)methyl)ornithine,
N-OMEGA-PROPYL-L-ARGININE,
137361-05-8,
omega-propyl-l-arginine,
Nomega-Propyl-L-arginine hydrochloride,
CHEMBL107528,
(S)-2-Amino-5-(3-propylguanidino)pentanoic acid,
(2S)-2-amino-5-[(N'-propylcarbamimidoyl)amino]pentanoic acid,
Nomega-Propyl-L-arginine,
hDDAH inhibitor, 2b,
NCGC00025034-01,
Nomegapropyl-L-arginine,
Tocris-1200,
N-?-Propyl-L-Arginine,
3AR,
2-amino-5-[(N'-propylcarbamimidoyl)amino]pentanoic acid,
AC1L9KK0,
N.omega.-propyl-L-Arginine,
GTPL6525,
SCHEMBL1004634,
CTK8E7922,
DTXSID30332245,
AOMXURITGZJPKB-ZETCQYMHSA-N,
BDBM235688,
ZINC1546170,
1950AH,
BDBM50240716,
AKOS015911666,
AJ-26878,
N5-[Imino(propylamino)methyl]-L-ornithine,
L-Ornithine,N5-[imino(propylamino)methyl]-,
RT-014077,
FT-0674094,
L-Ornithine, N5-[imino(propylamino)methyl]-,
2(S)-2-Amino-5-(N-propylguanidino)pentanoic acid,
J-007011,
I14-37930,
(2S)-2-amino-5-(3-propylcarbamimidamido)pentanoic acid,
(S)-2-Amino-5-(N''-propyl-guanidino)-pentanoic acid,
n-propyl-l-arginine,
D0O2KO,
C9H20N4O2,
CID447180,